We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Acquired pure red cell aplasia: updated review of treatment.
- Authors
Sawada, Kenichi; Fujishima, Naohito; Hirokawa, Makoto
- Abstract
Pure red cell aplasia (PRCA) is a syndrome characterized by a severe normocytic anaemia, reticulocytopenia, and absence of erythroblasts from an otherwise normal bone marrow. Primary PRCA, or secondary PRCA which has not responded to treatment of the underlying disease, is treated as an immunologically-mediated disease. Although vigorous immunosuppressive treatments induce and maintain remissions in a majority of patients, they carry an increased risk of serious complications. Corticosteroids were used in the treatment of PRCA and this has been considered the treatment of first choice although relapse is not uncommon. Cyclosporine A (CsA) has become established as one of the leading drugs for treatment of PRCA. However, common concerns have been the number of patients treated with CsA who achieve sustained remissions and the number that relapse. This article reviews the current status of CsA therapy and compares it to other treatments for diverse PRCAs.
- Publication
British journal of haematology, 2008, Vol 142, Issue 4, p505
- ISSN
1365-2141
- Publication type
Journal Article
- DOI
10.1111/j.1365-2141.2008.07216.x